Literature DB >> 12811246

The impact of cytomegalovirus infections and acute rejection episodes on the development of vascular changes in 6-month protocol biopsy specimens of cadaveric kidney allograft recipients.

Ilkka Helantera1, Petri Koskinen, Tom Tornroth, Raisa Loginov, Carola Gronhagen-Riska, Irmeli Lautenschlager.   

Abstract

BACKGROUND: The role of cytomegalovirus (CMV) in chronic kidney allograft rejection remains controversial. The purpose of this study was to examine the impact of CMV infection on histopathologic changes in 6-month protocol biopsy specimens of kidney allografts.
METHODS: Altogether, 52 renal allograft recipients were studied. CMV infection was diagnosed by CMV antigenemia test, viral cultures from blood and urine, or both. CMV was demonstrated in the biopsy specimens by antigen detection and hybridization in situ. Acute rejections were diagnosed by biopsy histology, and biopsy specimens were graded according to the Banff '97 classification.
RESULTS: CMV infection was diagnosed in 41 patients. The 11 patients in whom CMV infection was not detected were used as controls. Acute rejection was diagnosed in 22 of 41 CMV patients and in 6 of 11 control patients. CMV was demonstrated in the biopsy specimens of 19 of 41 CMV patients. CMV was not associated with increased glomerular, tubular, or interstitial changes. However, the arteriosclerotic changes in small arterioles were significantly increased in the subgroup of patients where CMV was demonstrated in the graft as compared with controls (P<0.01). Analysis of the impact of acute rejection on arteriolar thickening showed that only a positive history of both acute rejection and CMV found in the graft was associated with significantly increased vascular changes compared with CMV-free recipients (P<0.05).
CONCLUSIONS: Neither CMV nor acute rejection alone was associated with increased vascular or other histopathologic changes in 6-month protocol biopsy specimens of kidney allografts, but a previous history of both acute rejection and the presence of CMV in the graft was associated with increased vascular changes.

Entities:  

Mesh:

Year:  2003        PMID: 12811246     DOI: 10.1097/01.TP.0000064709.20841.E1

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  12 in total

Review 1.  Viral subversion mechanisms in chronic kidney disease pathogenesis.

Authors:  Leslie A Bruggeman
Journal:  Clin J Am Soc Nephrol       Date:  2007-07       Impact factor: 8.237

2.  Ganciclovir transiently attenuates murine cytomegalovirus-associated renal allograft inflammation.

Authors:  Masako Shimamura; Ute Saunders; Brian Rha; Lingling Guo; Kevin A Cassady; James F George; William J Britt
Journal:  Transplantation       Date:  2011-10-15       Impact factor: 4.939

3.  Cytomegalovirus infection leads to microvascular dysfunction and exacerbates hypercholesterolemia-induced responses.

Authors:  Mikhail V Khoretonenko; Igor L Leskov; Stephen R Jennings; Andrew D Yurochko; Karen Y Stokes
Journal:  Am J Pathol       Date:  2010-08-27       Impact factor: 4.307

Review 4.  Combating chronic renal allograft dysfunction : optimal immunosuppressive regimens.

Authors:  Pierre Merville
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Induction of an epithelial integrin alphavbeta6 in human cytomegalovirus-infected endothelial cells leads to activation of transforming growth factor-beta1 and increased collagen production.

Authors:  Takako Tabata; Hisaaki Kawakatsu; Ekaterina Maidji; Takao Sakai; Keiko Sakai; June Fang-Hoover; Motohiko Aiba; Dean Sheppard; Lenore Pereira
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

Review 6.  Viral infection in renal transplant recipients.

Authors:  Jovana Cukuranovic; Sladjana Ugrenovic; Ivan Jovanovic; Milan Visnjic; Vladisav Stefanovic
Journal:  ScientificWorldJournal       Date:  2012-05-02

Review 7.  Cytomegalovirus infection in renal transplantation: clinical aspects, management and the perspectives.

Authors:  Lúcio Roberto Requião-Moura; Ana Cristina Carvalho deMatos; Alvaro Pacheco-Silva
Journal:  Einstein (Sao Paulo)       Date:  2015 Jan-Mar

8.  A high burden of cytomegalovirus marks poor vascular health in transplant recipients more clearly than in the general population.

Authors:  Silvia Lee; Emily Brook; Jacquita Affandi; Prue Howson; Selita Agnes Tanudjaja; Satvinder Dhaliwal; Ashley Irish; Patricia Price
Journal:  Clin Transl Immunology       Date:  2019-02-11

9.  Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients.

Authors:  Adrian Egli; Isabelle Binet; Simone Binggeli; Clemens Jäger; Alexis Dumoulin; Stefan Schaub; Juerg Steiger; Urban Sester; Martina Sester; Hans H Hirsch
Journal:  J Transl Med       Date:  2008-06-09       Impact factor: 5.531

Review 10.  Cytomegalovirus infection in immunosuppressed patients after kidney transplantation.

Authors:  Simona Luscalov; Luminita Loga; Lucia Dican; Lia Monica Junie
Journal:  Clujul Med       Date:  2016-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.